NIH Funding Opportunities (Notices, PA, RFA)

Subscribe to NIH Funding Opportunities (Notices, PA, RFA) feed
Weekly Funding Opportunities and Policy Notices from the National Institutes of Health.
Updated: 12 min 26 sec ago

International Centers of Excellence for Malaria Research (U19 Clinical Trial Not Allowed)

Tue, 2022-11-22 11:32
Funding Opportunity RFA-AI-22-067 from the NIH Guide for Grants and Contracts. This Funding opportunity Announcement (FOA) solicits applications for the International Centers of Excellence for Malaria Research (ICEMR) Program, a multidisciplinary network of centers that will conduct research in malaria-endemic sites to 1) improve our understanding of malaria pathogenesis, epidemiology, and transmission; and 2) evaluate, optimize, and inform development of interventions to understand, control, eliminate, and eventually eradicate malaria. This program is intended to support research that is conducted primarily in countries in which malaria is endemic, and must provide for significant involvement of local/regional researchers in study design, development, and execution.

Leading Equity and Diversity in the Medical Scientist Training Program (LEAD MSTP)(T32)

Tue, 2022-11-22 11:11
Funding Opportunity PAR-23-030 from the NIH Guide for Grants and Contracts. The goal of the Leading Equity and Diversity in the Medical Scientist Training Program (LEAD MSTP) is to develop a diverse pool of highly trained clinician-scientist leaders available to meet the Nations biomedical research needs by providing support for dual-degree clinician scientist training at institutions that have historically not been well represented among NIGMS-funded MSTPs. Specifically, this Funding Opportunity Announcement (FOA) provides support to eligible domestic institutions to develop and implement effective, evidence-informed approaches to fully integrate the transitional phases of dual-degree training and mentoring that will lead to the completion of both clinical degrees (e.g., M.D., D.O., D.V.M., D.D.S., Pharm.D., etc.), and research doctorate degrees (Ph.D.) and keep pace with the rapid evolution of the biomedical enterprise. With the dual qualification of a rigorous scientist and clinician, graduates will be equipped with the skills to develop research programs that accelerate the translation of research advances to the understanding, detection, treatment, and prevention of human disease, and to lead the advancement of biomedical research. Areas of particular importance to NIGMS are optimizing training efficiency, fostering the persistence of alumni in research careers, and enhancing the diversity of the clinician-scientist workforce. NIGMS expects that the proposed research training programs will incorporate didactic, research, mentoring and career development elements to prepare trainees for careers that will have a significant impact on the health-related research needs of the Nation. This program is limited to dual-degree training programs at (1) Historically Black Colleges and Universities (HBCUs), (2) Tribal Colleges and Universities (TCUs), and (3) institutions in the states and territories that participate in the Institutional Development Award (IDeA) program, a congressionally mandated program that builds research capacity in state.

Findings of Research Misconduct

Tue, 2022-11-22 10:59
Notice NOT-OD-23-024 from the NIH Guide for Grants and Contracts

Notice of Correction to RFA-CA-22-050, NCI Cancer Moonshot Scholars Diversity Program (CMSDP) (R01 Clinical Trial Optional)".

Tue, 2022-11-22 10:57
Notice NOT-CA-22-132 from the NIH Guide for Grants and Contracts

Mechanistic links between diet, lipid metabolism, and tumor growth and progression (U01 Clinical Trial Not Allowed)

Mon, 2022-11-21 12:19
Funding Opportunity PAR-23-051 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement is to request applications that propose mechanistic investigations of the links between diet, lipid metabolism and tumor growth and progression. It is anticipated that this program will support fundamental studies designed to identify and define the molecular mechanisms through which lipid metabolism mediates tumor growth and progression, focusing specifically on the central role lipids play in linking diet with the biology of cancer; bridge the historically divided fields of nutrition and molecular metabolism; and stimulate research and tool development in this emerging area, which faces particular challenges because of the complexity of lipid biochemistry.

Mechanistic links between diet, lipid metabolism, and tumor growth and progression (UH2 Clinical Trial Not Allowed)

Mon, 2022-11-21 12:18
Funding Opportunity PAR-23-052 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement is to request applications that propose mechanistic investigations of the links between diet, lipid metabolism and tumor growth and progression. It is anticipated that this program will support fundamental studies designed to identify and define the molecular mechanisms through which lipid metabolism mediates tumor growth and progression, focusing specifically on the central role lipids play in linking diet with the biology of cancer; bridge the historically divided fields of nutrition and molecular metabolism; and stimulate research and tool development in this emerging area, which faces particular challenges because of the complexity of lipid biochemistry. For this announcement, unpublished preliminary data are limited to one figure, comprising no more than one-half page, to facilitate the entry of qualified new investigators to the field.

Research Infrastructure Development for Interdisciplinary Aging Studies (R61/R33 - Clinical Trial Optional)

Mon, 2022-11-21 12:18
Funding Opportunity PAR-23-053 from the NIH Guide for Grants and Contracts. This FOA invites applications that propose to develop novel research infrastructure that will advance the science of aging in specific areas requiring interdisciplinary partnerships or collaborations. This FOA will use the NIH Phased Innovation Award (R61/R33) mechanism to provide up to 2 years of R61 support for initial developmental activities and up to 3 years of R33 support for expanded activities. Through this award, investigators will develop a sustainable research infrastructure to support projects that address key interdisciplinary aging research questions.

Advanced-Stage Development and Utilization of Research Infrastructure for Interdisciplinary Aging Studies (R33 Clinical Trial Optional)

Mon, 2022-11-21 12:17
Funding Opportunity PAR-23-054 from the NIH Guide for Grants and Contracts. This FOA invites applications that propose to develop novel research infrastructure that will advance the science of aging in specific areas requiring interdisciplinary partnerships or collaborations.

Ancillary Studies to Ongoing Clinical Projects (R01 Clinical Trial Not Allowed)

Mon, 2022-11-21 10:07
Funding Opportunity PAR-23-025 from the NIH Guide for Grants and Contracts. Ancillary Studies to Ongoing Clinical Projects (R01 Clinical Trial Not Allowed)

Ancillary Studies to Ongoing Clinical Projects (R21 Clinical Trial Not Allowed)

Mon, 2022-11-21 10:07
Funding Opportunity PAR-23-026 from the NIH Guide for Grants and Contracts. Ancillary Studies to Ongoing Clinical Projects (R21 Clinical Trial Not Allowed)

Notice of Special Interest: Promoting Research Opportunities on HIV/AIDS in NIAMS

Mon, 2022-11-21 09:39
Notice NOT-AR-23-004 from the NIH Guide for Grants and Contracts

Request for Information: Priorities for Cancer Prevention and Symptom Management Science at NCI

Mon, 2022-11-21 03:57
Notice NOT-CA-23-016 from the NIH Guide for Grants and Contracts

Chronic Kidney Disease in Children Central Biochemistry Laboratory (U24 Clinical Trial Not Allowed)

Fri, 2022-11-18 03:30
Funding Opportunity RFA-DK-23-002 from the NIH Guide for Grants and Contracts. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), in collaboration with the National Heart, Lung and Blood Institute (NHLBI) and the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), invites applications for the Central Biochemistry Laboratory (CBL) for the Chronic Kidney Disease in Children Study (CKiD) Consortium. The CBL will work cooperatively with the existing Clinical Coordinating Centers (CCCs) and the Data Coordinating Center (DCC) of the study as a consortium.

Interventions that Address Structural Racism to Reduce Kidney Health Disparities Research Coordinating Center (U24 - Clinical Trial Not Allowed)

Fri, 2022-11-18 03:30
Funding Opportunity RFA-DK-23-003 from the NIH Guide for Grants and Contracts. TheInterventions that Address Structural Racism to Reduce Kidney Health DisparitiesConsortium aims to foster community-engaged intervention research to address structural racism to reduce health disparities among individuals living with kidney disease. The Consortium will consist of one Research Coordinating Center and multiple Intervention Sites (seeRFA-DK-22-014)that will work collaboratively to develop, implement and evaluate meaningful interventions that aim to dismantle or mitigate the effects of structural racism to reduce kidney health disparities. This Funding Opportunity Announcement (FOA) invites applications for theResearch Coordinating Center(RCC) that will lead, manage, and harmonize efforts for the Consortium. The specific activities of the RCC will include: 1) providing organization, management, and administrative support of Consortium activities; 2) providing research coordination, data management and data analyses for Consortium studies; and 3) fostering research collaborations and helping to build a community of investigators with skills to develop, implement, and disseminate effective, scalable, and sustainable interventions that address the structural drivers of kidney health disparities.

Pages